Skip to main content
. 2022 Jan 13;8:759311. doi: 10.3389/fmed.2021.759311

Figure 5.

Figure 5

Forest plots of proportion of MH closure in participants receiving ocriplasmin therapy in included cohort studies. (A) In all the participants; (B) In participants of MH diameter ≤ 250 μm; (C) In participants of MH diameter of 250–400 μm.